Data-driven identification of endophenotypes of Alzheimer’s disease progression: implications for clinical trials and therapeutic interventions

by Nophar Geifman, Richard E. Kennedy, Lon S. Schneider, Iain Buchan, Roberta Diaz Brinton
Published 2018-01-01

Neighborhood Disadvantage Is Associated with Depressive Symptoms but Not Depression Diagnosis in Older Adults

by Courtney J. Bolstad, Reagan Moak, Cynthia J. Brown, Richard E. Kennedy, David R. Buys
Published 2020-08-01

Ficolin-2 inhibitors are present in sera after prolonged storage at −80 °C

by Kimball Aaron Geno, Richard E. Kennedy, Patricia Sawyer, Cynthia J. Brown, Moon H. Nahm
Published 2016-11-01

Using practice effects for targeted trials or sub-group analysis in Alzheimer's disease: How practice effects predict change over time.

by Guoqiao Wang, Richard E Kennedy, Terry E Goldberg, Mackenzie E Fowler, Gary R Cutter, Lon S Schneider
Published 2020-01-01

The validity and power of extreme sampling schemes for mediation analysis

by Robert eMakowsky, T. Mark Beasley, Gary L. Gadbury, Jeffrey M. Albert, Richard E Kennedy, David B Allison
Published 2011-10-01

Clear and Consistent Imaging of Hippocampal Internal Architecture With High Resolution Multiple Image Co-registration and Averaging (HR-MICRA)

by Lawrence Ver Hoef, Lawrence Ver Hoef, Lawrence Ver Hoef, Hrishikesh Deshpande, Joel Cure, Goutham Selladurai, Julia Beattie, Richard E. Kennedy, Robert C. Knowlton, Jerzy P. Szaflarski
Published 2021-02-01

Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease

by Samantha M. Carlisle, Hongwei Qin, R. Curtis Hendrickson, Jordana E. Muwanguzi, Elliot J. Lefkowitz, Richard E. Kennedy, Zhaoqi Yan, Talene A. Yacoubian, Etty N. Benveniste, Andrew B. West, Ashley S. Harms, David G. Standaert
Published 2021-04-01